Search clinical trials for: Ranibizumab Injection [Lucentis]

Total 10264 results

Philip J. ferrone, M.D.

Completed

Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema

Clinically Significant Diabetic Macular Edema

United States
Wake Forest University Health Sciences
Modulight

Withdrawn

Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy

Exudative Age Related Macular Degeneration

United States
Retina Associates of Florida, P.A.

Completed

Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion (RaScaL)

Diabetic Macular Edema

United States
Aleris Helse
Novartis

Completed

A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

Central Retinal Vein Occlusion | Macular Edema

Norway
Ophthalmic Consultants of Boston
Genentech, Inc.

Completed

Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.

Choroidal Neovascularization
Bayer
Regeneron Pharmaceuticals

Completed

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) (VIEW 2)

Macular Degeneration

Belgium, Israel, Italy, Spain, Korea, Republic of, Switzerland, Germany, Portugal, Japan, France, Australia, Netherlands, India, Austria, Brazil, Poland, United Kingdom, Singapore, Hungary, Latvia, Mexico, Czech Republic, Colombia, Ar... and more
Moy-Fincher Medical Group

Unknown

The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure

Scars

United States
Bioeq GmbH

Completed

Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration (COLUMBUS-AMD)

Age-related Macular Degeneration (AMD)

France, Italy, Poland, Russian Federation, Spain, United Kingdom, Germany, Hungary, Ukraine, Austria, Czechia, Israel
Universiti Sains Malaysia

Completed

Effects of Ranibizumab in Primary Pterygium Surgery

Patients With Primary Nasal Pterygium

Malaysia
Novartis Pharmaceuticals

Terminated

Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase (CONSTELLATION)

Diabetes | Macular Degeneration | Macular Edema

France
Novartis Pharmaceuticals

Completed

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. (ECLIPSE)

Diabetic Retinopathy | Macular Edema | Choroidal Neovascularization | Glaucoma, Neovascular

France
Novartis

Completed

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen (REPAIR)

Choroidal Neovascularisation

United Kingdom
Vitreous -Retina- Macula Consultants of New York
Genentech, Inc.

Withdrawn

Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration (SEIRA)

Age Related Macular Degeneration | CNV | AMD

United States
Prof. Dr. Antonia M. Joussen
Charite University, Berlin, Germany

Terminated

Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab (DORO)

Macular Edema, Cystoid | Visual Acuity Reduced Transiently

Germany
Nagoya City University
Novartis

Completed

Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.

Neovascular Age-related Macular Degeneration

Japan
California Retina Consultants

Completed

Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab (ERASER)

Diabetic Macular Edema

United States
Genentech, Inc.

Completed

An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO

Choroidal Neovascularization, Age-related Macular Degeneration
Novartis Pharmaceuticals

Completed

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients (EXTEND II)

Age Related Macular Degeneration

China
Novartis Pharmaceuticals

Completed

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME) (RESPOND)

Diabetic Macular Edema

Canada
Brandon G. Busbee, MD
Genentech, Inc.

Completed

Evaluation of Dosing Interval of Higher Doses of Ranibizumab (BGB/IST)

Macular Degeneration | Choroidal Neovascularization

United States
Genentech, Inc.

Completed

A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Macular Degeneration

United States
Novartis

Completed

Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration

Age-Related Macular Degeneration (ARMD)

Switzerland
Western Galilee Hospital-Nahariya

Recruiting

Comparing Methods for Balloon Catheter Inserting: View Guided (Speculum) Versus Manual Guided at Cervical Examination

Cervical Ripening

Israel
Rothman Institute Orthopaedics

Unknown

Study Comparing One Versus Two Cortisone Injections for Trigger Finger

Trigger Finger | Stenosing Tenosynovitis

United States
Shanghai Henlius Biotech

Active, not recruiting

A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD

Age Related Macular Degeneration

United States, Singapore, Spain, Germany, Slovakia, China, Hungary, Australia, Bulgaria, Poland, Latvia, Czechia, France, Italy, Serbia
Fukushima Medical University

Unknown

Retinal Sensitivity in BRVO After Anti-VEGF Therapy

Branch Retinal Vein Occlusion

Japan
Genentech, Inc.

Completed

Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)

Macular Degeneration
Genentech, Inc.

Completed

A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Age-related Macular Degeneration | Choroidal Neovascularization
Yangzhou University

Not yet recruiting

Application of Different Modes of Esketamine Administration in Pediatric Day Circumcision

Pain
Novartis Pharmaceuticals

Completed

Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye (TWEYES)

Wet Age Related Macular Degeneration

Italy
University of Colorado, Denver
Genentech, Inc.

Completed

Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy (NAION)

Nonarteritic Anterior Ischemic Optic Neuropathy

United States
Ruijin Hospital
Ningbo University

Completed

Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma

Diabetic Retinopathy | Glaucoma, Neovascular
G. d'Annunzio University

Completed

Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema (LED)

Diabetic Macular Edema
Indiana University School of Medicine

Completed

Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy?

Colorectal Cancer | Colorectal Polyps

United States
McMaster University
St. Joseph's Healthcare Hamilton; Hamilton Health Sciences Corporation

Completed

OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab (STAR)

Wet Macular Degeneration

Canada
North Toronto Eye Care Laser and Eye Specialists
Allergan

Terminated

Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema (COLLIDE)

Diabetic Macular Edema

Canada
Moy-Fincher Medical Group

Completed

Burn Scar Appearance After Treatment With Fractional Carbon Dioxide (CO2) Laser

Scars

United States
Kyoto University, Graduate School of Medicine
Novartis

Unknown

Ranibizumab Treatment for Retinal Vein Occlusion

Macular Edema Due to BRVO/CRVO

Japan
Unity Health Toronto

Recruiting

Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab (COVERT)

Diabetic Macular Edema | Macular Edema | Retinal Vein Occlusion | Age Related Macular Degeneration

Canada
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion (RVO in Japan)

Retinal Vein Occlusion

Japan
Anne Fung MD
Genentech, Inc.

Terminated

HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration (HiPED)

Macular Degeneration | Wet Macular Degeneration | Retinal Pigment Epithelial Detachment

United States
Novartis Pharmaceuticals

Completed

A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections (RAZORBILL)

Neovascular Age-Related Macular Degeneration

Spain, Italy, Germany, Canada, Ireland
Lions Eye Institute, Perth, Western Australia
Adverum Biotechnologies, Inc.

Completed

Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration (AMD)

Eye Diseases | Macular Degeneration | Retinal Degeneration | Retinal Neovascularization | Age-related Maculopathies | Age-related Maculopathy | Maculopathies,Age-related | Maculopathy,Age-related

Australia
Genentech, Inc.

Completed

A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration

Macular Degeneration

United States, Australia, Czech Republic, France, Germany, Hungary
Theravectys S.A.

Not yet recruiting

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

HPV-Related Cervical Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma

United States
Makassed General Hospital

Recruiting

Effectiveness of Single Paravertebral Blockade Injection for Herniorrhaphy in Children

Reduce Pain After Herniorrhaphy

Lebanon
University of Guadalajara
Hospital Civil de Guadalajara

Unknown

Efect of Quinoa and Flaxseed in Cititoxicity and Glicemic Control in Metabolic Syndrome Patients

Metabolic Syndrome | Nutritional and Metabolic Diseases

Mexico
Genentech, Inc.

Completed

A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration

Macular Degeneration
Maisonneuve-Rosemont Hospital
Novartis

Completed

Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection of Ranibizumab

Glaucoma

Canada
Retina Consultants of Hawaii
Genentech, Inc.

Unknown

Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy (PEARL2)

Polypoidal Choroidal Vasculopathy

United States

3

Subscribe